Stryker (SYK) Income towards Parent Company (2009 - 2026)
Stryker (SYK) posted quarterly Income towards Parent Company of $1.3 billion for Q2 2026, up 44.34% year-over-year from $884.0 million in Q2 2025, and up 71.28% on a QoQ basis from $745.0 million in Q1 2026.
Stryker (SYK) Income towards Parent Company (2009 - 2026) Analysis & Trends
Stryker has reported Income towards Parent Company for 18 years, with the latest figure at $1.3 billion in Q2 2026.
- Income towards Parent Company for Q2 2026 came in at $1.3 billion, up 44.34% year-over-year; the trailing twelve-month figure through Jun 2026 was $3.7 billion (up 27.79% YoY), and the FY2025 annual result was $3.2 billion, up 8.45% from the prior year.
- Income towards Parent Company rose to $1.3 billion in Q2 2026, from $745.0 million in the prior quarter.
- Over five years, Income towards Parent Company peaked at $1.3 billion in Q2 2026 and troughed at $323.0 million in Q1 2022.
- A 5-year average of $765.7 million and a median of $766.5 million in 2024 frame the typical range for Income towards Parent Company.
- The widest annual swing landed in 2023, when Income towards Parent Company jumped 103.02%; it then plunged 52.23% in 2024.
- A 5-year view of Income towards Parent Company shows it stood at $563.0 million in 2022, then jumped by 103.02% to $1.1 billion in 2023, then plunged by 52.23% to $546.0 million in 2024, then soared by 55.49% to $849.0 million in 2025, then surged by 50.29% to $1.3 billion in 2026.
- Per Business Quant data, the three most recent Income towards Parent Company figures were $1.3 billion in Q2 2026, $745.0 million in Q1 2026, and $849.0 million in Q4 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.70 Bn | 194.09 Bn | 7.27 Bn |
| 2 | Stryker | 129.93 Bn | 126.46 Bn | 4.50 Bn |
| 3 | Medtronic | 120.49 Bn | 111.27 Bn | 6.41 Bn |
| 4 | Boston Scientific | 74.60 Bn | 74.06 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 52.68 Bn | 48.42 Bn | 1.35 Bn |
| 6 | Dexcom | 34.78 Bn | 32.84 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.83 Bn | 31.72 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.44 Bn | 23.12 Bn | 4.55 Bn |
| 9 | Steris | 23.18 Bn | 22.69 Bn | 684.20 Mn |
| 10 | Zimmer Biomet Holdings | 19.40 Bn | 18.99 Bn | 1.54 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.28 Bn |
| Mar 31, 2026 | 745.00 Mn |
| Dec 31, 2025 | 849.00 Mn |
| Sep 30, 2025 | 859.00 Mn |
| Jun 30, 2025 | 884.00 Mn |
| Mar 31, 2025 | 654.00 Mn |
| Dec 31, 2024 | 546.00 Mn |
| Sep 30, 2024 | 834.00 Mn |
| Jun 30, 2024 | 825.00 Mn |
| Mar 31, 2024 | 788.00 Mn |
| Dec 31, 2023 | 1.14 Bn |
| Sep 30, 2023 | 692.00 Mn |
| Jun 30, 2023 | 738.00 Mn |
| Mar 31, 2023 | 592.00 Mn |
| Dec 31, 2022 | 563.00 Mn |
| Sep 30, 2022 | 816.00 Mn |
| Jun 30, 2022 | 656.00 Mn |
| Mar 31, 2022 | 323.00 Mn |
| Dec 31, 2021 | 662.00 Mn |
| Sep 30, 2021 | 438.00 Mn |